Quarterly report pursuant to Section 13 or 15(d)

Stock Option-Based Compensation and Restricted Stock Compensation

v3.8.0.1
Stock Option-Based Compensation and Restricted Stock Compensation
 9 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Based Compensation and Restricted Stock Compensation
(4)        Stock Option-Based Compensation and Restricted Stock Compensation
 
For the three and nine months ended September 30, 2017, we recognized stock option-based compensation expense of $792,000 and $3,527,000, respectively. For the three and nine months ended September 30, 2016 we recognized stock option-based compensation expense of $917,000 and $3,894,000, respectively.
 
For the three and nine months ended September 30, 2017, we granted no stock options and 185,000 stock options, respectively, and for the three and nine months ended September 30, 2016, we granted no stock options and 1,440,000 stock options, respectively.
 
The following table summarizes stock option-based compensation for the three and nine months ended September 30, 2017 and 2016:
 
 
 
Three months ended
 
Nine months ended
 
 
 
September 30,
 
September 30,
 
 
 
2017
 
2016
 
2017
 
2016
 
Research and development
 
$
394,000
 
$
274,000
 
$
1,118,000
 
$
937,000
 
General and administrative
 
 
398,000
 
 
643,000
 
 
2,409,000
 
 
2,957,000
 
Stock option-based compensation expense included in operating expense
 
$
792,000
 
$
917,000
 
$
3,527,000
 
$
3,894,000
 
 
For the three and nine months ended September 30, 2017, we recognized restricted common stock compensation expense of $293,000 and $979,000, respectively for granted restricted common stock. For the three and nine months ended September 30, 2016 we recognized restricted stock compensation expense of $241,000 and $3,120,000, respectively for granted restricted common stock.
 
For the three and nine months ended September 30, 2017 and September 30, 2016 no common stock was granted to directors or employees.
 
The following table summarizes restricted common stock compensation expense for the three and nine months ended September 30, 2017 and 2016:
 
 
 
Three months ended
 
Nine months ended
 
 
 
September 30,
 
September 30,
 
 
 
2017
 
2016
 
2017
 
2016
 
Research and development
 
$
-
 
$
-
 
$
-
 
$
200,000
 
General and administrative
 
 
293,000
 
 
241,000
 
 
979,000
 
 
2,920,000
 
Restricted stock compensation expense included in operating expense
 
$
293,000
 
$
241,000
 
$
979,000
 
$
3,120,000